Acute pancreatitis in a patient treated with imatinib and gefitinib
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155220949639
Abstract: Introduction Use of oral antineoplastic agents (OAAs) has increased significantly in recent years. OAAs currently represent 30-50% of all cancer treatments. Drug interactions are the most frequent drug-related problem affecting OAAs. We describe the case… read more here.
Keywords: acute pancreatitis; gefitinib; treated imatinib; imatinib gefitinib ... See more keywords